Lawsuit: CVS Caremark inflated drug costs via ‘manipulation scheme’

robot
Abstract generation in progress

CVS Caremark is facing a lawsuit filed by a roofers’ union, alleging the company inflated prescription drug costs through a “Formulary Manipulation Scheme.” The lawsuit claims Caremark used its control over drug formularies to favor higher-cost medications, channeling payments through its subsidiary Zinc Health Services instead of securing better rebates for clients. This practice allegedly led to increased costs for plan sponsors and members, leading the union to seek recovery of losses and other damages.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments